Vedolizumab

Vedolizumab
Measuring Vedolizumab drug concentrations in patients being treated with Vedolizumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Vedolizumab allows for reliable measurement of Vedolizumab drug levels using just a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes. This allows clinicians to confirm the drug levels of Vedolizumab immediately before the next administration.

About Using Reagent

• Sample Types Whole blood, Serum, and Plasma
• Reaction Time 10 mins
  
• Detection Range 2~60 μg/mL
  
• Indication Quantitative determination of free Vedolizumab in human whole blood/serum/plasma
  

Click